Skip to main content

Full text of "USPTO Patents Application 08479810"

See other formats


United States Patent and Trademark Office 



ss: COMMISSIONER FOR PATENTS 



NOTICE OF ALLOWANCE AND FEE(S) DUE 



06/29/2011 



IBM CORPORATION, T J. WATSON RESEARCH CENTER kopec, mark t 

P.O. BOX 218 



YORKTOWN HEIGHTS, NY 10598 art unit paper number 



DATE MAILED: 06/29/201 1 



APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 



JOHANNES G. BEDNORZ YOR919870074US5 



| APPLN. TYPE | SMALL ENTITY | ISSUE FEE DUE | PUBLICATION FEE DUE | PREV. PAID ISSUE FEE | TOTAL FEE(S) DUE | DATE DUE | 

nonprovisional YES $755 $0 $0 $755 09/29/2011 

THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT. 
PROSECUTION ON THE MERITS IS CLOSED . THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS. 
THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON 
PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308. 

THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE 
MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED. THIS 
STATUTORY PERIOD CANNOT BE EXTENDED . SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES 
NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION. IF AN ISSUE FEE HAS 
PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM 
WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW 
DUE. 



HOW TO REPLY TO THIS NOTICE: 



I. Review the SMALL ENTITY status shown above. 

If the SMALL ENTITY is shown as YES, verify your current 
SMALL ENTITY status: 

A. If the status is the same, pay the TOTAL FEE(S) DUE shown 
above. 

B. If the status above is to be removed, check box 5b on Part B - 
Fee(s) Transmittal and pay the PUBLICATION FEE (if required) 
and twice the amount of the ISSUE FEE shown above, or 



If the SMALL ENTITY is shown as NO: 



A. Pay TOTAL FEE(S) DUE shown above, or 



B. If applicant claimed SMALL ENTITY status before, or is now 
claiming SMALL ENTITY status, check box 5a on Part B - Fee(s) 
Transmittal and pay the PUBLICATION FEE (if required) and 1/2 
the ISSUE FEE shown above. 



II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office 
(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b" 
of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a 
request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing 
the paper as an equivalent of Part B. 

III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to 
Mail Stop ISSUE FEE unless advised to the contrary. 

IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of 
maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due. 

Page 1 of 3 



PTOL-85 (Rev. 02/1 1) 



PART B - FEE(S) TRANSMITTAL 

Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE 

Commissioner for Patents 
P.O. Box 1450 

Alexandria, Virginia 22313-1450 
or Fax (571)-273-2885 

INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1 through 5 should be completed where 
appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as 
indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for 

jtifications. 

LESS (Note: Use Block 1 for any change of address) Note: A certificate of mailing can only be used for domestic mailings of the 

Fee(s) Transmittal. This certificate cannot be used for any other accompanying 
papers. Each additional paper, such as an assignment or formal drawing, must 
have its own certificate of m '' 

877 7590 06/29/2011 

IBM CORPORATION, T J. WATSON RESEARCH CENTER 
P.O. BOX 218 

YORKTOWN HEIGHTS, NY 10598 



Certificate of Mailing or Transmission 

I hereby certify that this Fee(s) Transmittal is being deposited with the United 
States Postal Service with sufficient postage for first class mail in an envelope 



APPLICATION NO. 



FILING DATE 



FIRST NAMED INVENTOR 



JOHANNES G. BEDNORZ 



ATTORNEY DOCKET NO. CONFIRMATION NO. 



YOR919870074US5 



APPLN. TYPE 



SMALL ENTITY 



ISSUE FEE DUE PUBLICATION FEE DUE PREV. PAID ISSUE FEE TOTAL FEE(S) DUE 



KOPEC, MARK T 



1761 

: "Fee Address" (37 



CLASS-SUBCLASS 



2. For printing on the patent front page, list 

(1) the names of up to 3 registered patent attorneys 
or agents OR, alternatively, 

(2) the name of a single firm (having as a member a 
registered attorney or agent) and the names of up to 
2 registered patent attorneys or agents. If no name is 
listed, no name will be printed. 



1. Change of correspondence address or ii 
CFR 1.363). 

Q Change of correspondence address (or Change of Correspondence 
Address form PTO/SB/122) attached. 

Q "Fee Address" indication (or "Fee Address" Indication form 
PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer 
Number is required. 

3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type) 

PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent. If an assignee is identified below, the document has been filed for 
recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment. 

(A) NAME OF ASSIGNEE (B) RESIDENCE: (CITY and STATE OR COUNTRY) 



Please check the appropriate assignee category or categories (will not be printed on the patent) : Q Individual Q Corporation or other private group entity Q Governmenl 

ted: 4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above) 

Q A check is enclosed. 

Q Publication Fee (No small entity discount permitted) Q Payment by credit card. Form PTO-2038 is attached. 

Q Advance Order - # of Copies Q The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any 

overpayment, to Deposit Account Number (enclose an extra copy of this form). 

5. Change in Entity Status (from status indicated above) 

□ a. Applicant claims SMALL ENTITY status. See 37 CFR 1.27. □ b. Applicant is no longer claiming SMALL ENTITY status. See 37 CFR 1.27(g)(2). 

NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party ir 
interest as shown by the records of the United States Patent and Trademark Office. 

Signature Date 



Typed or printed name Registration No. _ 



This collection of information is required by 37 CFR 1.31 1. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) 
an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete, including gathering, preparing, and 
submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete 
this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. 
Box 1450, Alexandria, Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, 
Alexandria, Virginia 22313-1450. 

Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. 



PTOL-85 (Rev. 02/1 1) Approved for use through 08/3 1/2013. 



OMB 0651-0033 



U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE 



United States Patent and Trademark Office 



ss: COMMISSIONER FOR PATENTS 



APPLICATION NO. 



FILING DATE 



FIRST NAMED INVENTOR 
JOHANNES G. BEDNORZ 



| ATTORNEY DOCKET NO. | CONFIRMATION NO. 
YOR919870074US5 8594 



877 7590 06/29/2011 

IBM CORPORATION, T J. WATSON RESEARCH CENTER 
P.O. BOX 218 

YORKTOWN HEIGHTS, NY 10598 



KOPEC, MARK T 



PAPER NUMBER 



DATE MAILED: 06/29/201 1 



Determination of Patent Term Extension or Adjustment under 35 U.S.C. 154 (b) 

(application filed prior to June 8, 1995) 

This patent application was filed prior to June 8, 1995, thus no Patent Term Extension or Adjustment applies. 

Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of 
Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be 
directed to the Customer Service Center of the Office of Patent Publication at l-(888)-786-0101 or (571)-272-4200. 



PTOL-85 (Rev. 02/1 1) 



Page 3 of 3 



Privacy Act Statement 



The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with 
your submission of the attached form related to a patent application or patent. Accordingly, pursuant to 
the requirements of the Act, please be advised that: (1) the general authority for the collection of this 
information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the 
principal purpose for which the information is used by the U.S. Patent and Trademark Office is to process 
and/or examine your submission related to a patent application or patent. If you do not furnish the 
requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine 
your submission, which may result in termination of proceedings or abandonment of the application or 
expiration of the patent. 

The information provided by you in this form will be subject to the following routine uses: 

1 . The information on this form will be treated confidentially to the extent allowed under the Freedom 
of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of 
records may be disclosed to the Department of Justice to determine whether disclosure of these 
records is required by the Freedom of Information Act. 

2. A record from this system of records may be disclosed, as a routine use, in the course of presenting 
evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel 
in the course of settlement negotiations. 

3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress 
submitting a request involving an individual, to whom the record pertains, when the individual has 
requested assistance from the Member with respect to the subject matter of the record. 

4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency 
having need for the information in order to perform a contract. Recipients of information shall be 
required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 
U.S.C. 552a(m). 

5. A record related to an International Application filed under the Patent Cooperation Treaty in this 
system of records may be disclosed, as a routine use, to the International Bureau of the World 
Intellectual Property Organization, pursuant to the Patent Cooperation Treaty. 

6. A record in this system of records may be disclosed, as a routine use, to another federal agency for 
purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy 
Act (42 U.S.C. 218(c)). 

7. A record from this system of records may be disclosed, as a routine use, to the Administrator, 
General Services, or his/her designee, during an inspection of records conducted by GSA as part of 
that agency's responsibility to recommend improvements in records management practices and 
programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance 
with the GSA regulations governing inspection of records for this purpose, and any other relevant 
(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about 
individuals. 

8. A record from this system of records may be disclosed, as a routine use, to the public after either 
publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 
U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a 
routine use, to the public if the record was filed in an application which became abandoned or in 
which the proceedings were terminated and which application is referenced by either a published 
application, an application open to public inspection or an issued patent. 

9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local 
law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or 
regulation. 



Application No. 



Applicant(s) 



Interview Summary 



08/479,810 



BEDNORZ ET AL. 



Examiner 



Art Unit 



MARK KOPEC 



1761 



All participants (applicant, applicant's representative, PTO personnel): 



(1) MARK KOPEC . 



(3) ■ 



(2) Dr. Daniel P. Morris, Esq . 



(4) . 



Date of Interview: 20 June 2011 . 

Type: a)M Telephonic b)D Video Conference 

c)D Personal [copy given to: 1)D applicant 2)D applicant's representative] 

Exhibit shown or demonstration conducted: d)D Yes e)D No. 
If Yes, brief description: . 

Claim(s) discussed: all- 

Identification of prior art discussed: . 

Agreement with respect to the claims f)^ was reached. g)D was not reached. h)D N/A. 



Substance of Interview including description of the general nature of what was agreed to if an agreement was 
reached, or any other comments: Dependent claims amended in order to clarify and/or further limit the preceding 
independent claims from which they depend. Additionally, new claims directed to "persistent current" added (see 
applicant's remarks filed 02/22/11). . 

(A fuller description, if necessary, and a copy of the amendments which the examiner agreed would render the claims 
allowable, if available, must be attached. Also, where no copy of the amendments that would render the claims 
allowable is available, a summary thereof must be attached.) 

THE FORMAL WRITTEN REPLY TO THE LAST OFFICE ACTION MUST INCLUDE THE SUBSTANCE OF THE 
INTERVIEW. (See MPEP Section 713.04). If a reply to the last Office action has already been filed, APPLICANT IS 
GIVEN A NON-EXTENDABLE PERIOD OF THE LONGER OF ONE MONTH OR THIRTY DAYS FROM THIS 
INTERVIEW DATE, OR THE MAILING DATE OF THIS INTERVIEW SUMMARY FORM, WHICHEVER IS LATER, TO 
FILE A STATEMENT OF THE SUBSTANCE OF THE INTERVIEW. See Summary of Record of Interview 
requirements on reverse side or on attached sheet. 



/Mark Kopec/ 

Primary Examiner, Art Unit 1761 

U.S. Patent and Trademark Office 

PTOL-41 3 (Rev. 04-03) Interview Summary Paper No. 201 1 0620 



Summary of Record of Interview Requirements 



Manual of Patent Examining Procedure (MPEP), Section 713.04, Substance of Interview Must be Made of Record 

A complete written statement as to the substance of any face-to-face, video conference, or telephone interview with regard to an application must be made of record in the 
application whether or not an agreement with the examiner was reached at the interview. 

Title 37 Code of Federal Regulations (CFR) § 1.133 Interviews 

Paragraph (b) 

In every instance where reconsideration is requested in view of an interview with an examiner, a complete written statement of the reasons presented at the interview as 
warranting favorable action must be filed by the applicant. An interview does not remove the necessity for reply to Office action as specified in §§ 1 .11 1 , 1 .135. (35 U.S.C. 132) 



37 CFR §1 .2 Business to be transacted in writing. 
All business with the Patent or Trademark Office should be transacted in writing. The personal attendance of applicants or their attorneys or agents at the Patent and 
Trademark Office is unnecessary. The action of the Patent and Trademark Office will be based exclusively on the written record in the Office. No attention will be paid to 
any alleged oral promise, stipulation, or understanding in relation to which there is disagreement or doubt. 



The action of the Patent and Trademark Office cannot be based exclusively on the written record in the Office if that record is itself 
incomplete through the failure to record the substance of interviews. 

It is the responsibility of the applicant or the attorney or agent to make the substance of an interview of record in the application file, unless 
the examiner indicates he or she will do so. It is the examiner's responsibility to see that such a record is made and to correct material inaccuracies 
which bear directly on the question of patentability. 

Examiners must complete an Interview Summary Form for each interview held where a matter of substance has been discussed during the 
interview by checking the appropriate boxes and filling in the blanks. Discussions regarding only procedural matters, directed solely to restriction 
requirements for which interview recordation is otherwise provided for in Section 812.01 of the Manual of Patent Examining Procedure, or pointing 
out typographical errors or unreadable script in Office actions or the like, are excluded from the interview recordation procedures below. Where the 
substance of an interview is completely recorded in an Examiners Amendment, no separate Interview Summary Record is required. 

The Interview Summary Form shall be given an appropriate Paper No., placed in the right hand portion of the file, and listed on the 
"Contents" section of the file wrapper. In a personal interview, a duplicate of the Form is given to the applicant (or attorney or agent) at the 
conclusion of the interview. In the case of a telephone or video-conference interview, the copy is mailed to the applicant's correspondence address 
either with or prior to the next official communication. If additional correspondence from the examiner is not likely before an allowance or if other 
circumstances dictate, the Form should be mailed promptly after the interview rather than with the next official communication. 

The Form provides for recordation of the following information: 

- Application Number (Series Code and Serial Number) 

- Name of applicant 

- Name of examiner 

- Date of interview 

- Type of interview (telephonic, video-conference, or personal) 

- Name of participant(s) (applicant, attorney or agent, examiner, other PTO personnel, etc.) 

- An indication whether or not an exhibit was shown or a demonstration conducted 

- An identification of the specific prior art discussed 

- An indication whether an agreement was reached and if so, a description of the general nature of the agreement (may be by 
attachment of a copy of amendments or claims agreed as being allowable). Note: Agreement as to allowability is tentative and does 
not restrict further action by the examiner to the contrary. 

- The signature of the examiner who conducted the interview (if Form is not an attachment to a signed Office action) 

It is desirable that the examiner orally remind the applicant of his or her obligation to record the substance of the interview of each case. It 
should be noted, however, that the Interview Summary Form will not normally be considered a complete and proper recordation of the interview 
unless it includes, or is supplemented by the applicant or the examiner to include, all of the applicable items required below concerning the 
substance of the interview. 

A complete and proper recordation of the substance of any interview should include at least the following applicable items: 

1) A brief description of the nature of any exhibit shown or any demonstration conducted, 

2) an identification of the claims discussed, 

3) an identification of the specific prior art discussed, 

4) an identification of the principal proposed amendments of a substantive nature discussed, unless these are already described on the 
Interview Summary Form completed by the Examiner, 

5) a brief identification of the general thrust of the principal arguments presented to the examiner, 

(The identification of arguments need not be lengthy or elaborate. A verbatim or highly detailed description of the arguments is not 
required. The identification of the arguments is sufficient if the general nature or thrust of the principal arguments made to the 
examiner can be understood in the context of the application file. Of course, the applicant may desire to emphasize and fully 
describe those arguments which he or she feels were or might be persuasive to the examiner.) 

6) a general indication of any other pertinent matters discussed, and 

7) if appropriate, the general results or outcome of the interview unless already described in the Interview Summary Form completed by 
the examiner. 

Examiners are expected to carefully review the applicant's record of the substance of an interview. If the record is not complete and 
accurate, the examiner will give the applicant an extendable one month time period to correct the record. 

Examiner to Check for Accuracy 

If the claims are allowable for other reasons of record, the examiner should send a letter setting forth the examiner's version of the 
statement attributed to him or her. If the record is complete and accurate, the examiner should place the indication, "Interview Record OK" on the 
paper recording the substance of the interview along with the date and the examiner's initials.